Penumbra
PEN
#1836
Rank
โ‚น765.68 B
Marketcap
โ‚น19,950
Share price
1.45%
Change (1 day)
30.22%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น31.62 Billion

According to Penumbra's latest financial reports the company's total liabilities are โ‚น31.62 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Penumbra - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น31.41 B2.04%
2022-12-31โ‚น30.78 B42.46%
2021-12-31โ‚น21.60 B59.55%
2020-12-31โ‚น13.54 B5.35%
2019-12-31โ‚น12.85 B98.58%
2018-12-31โ‚น6.47 B32.96%
2017-12-31โ‚น4.86 B71.8%
2016-12-31โ‚น2.83 B36.14%
2015-12-31โ‚น2.08 B-75.44%
2014-12-31โ‚น8.47 B73.23%
2013-12-31โ‚น4.89 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น22.14 B-29.98%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น88.98 B 181.37%๐Ÿ‡บ๐Ÿ‡ธ USA